收入
成本
利润
| Item | Category | Value | YoY |
|---|---|---|---|
| Total revenues | revenue | 1.27B | 20.87% |
| Interest income | revenue | 33.69M | 46.92% |
| Gain (loss) on equity investments | revenue | 6.59M | 390.77% |
| Other, net | revenue | 2.77M | -65.74% |
| Income from operations | profit | 301.12M | 46.77% |
| Total costs, expenses and other | cost | 971.56M | 14.61% |
| (gain) loss on change in fair value of acquisition-related contingent consideration | cost | 168000 | -98.55% |
| Aggregate | revenue | 344.17M | 45.72% |
| Aggregate | cost | 971.73M | 311.41% |
| Income before provision for income taxes | profit | 343.60M | 46.72% |
| Interest expense, nonoperating | cost | 569000 | -13.79% |
| Research and development | cost | 515.90M | 17.98% |
| Selling, general and administrative | cost | 328.09M | 0.74% |
| Cost of sales (including definite-lived intangible amortization) | cost | 104.52M | 42.81% |
| Asset impairment and related disposal costs | cost | 23.21M | |
| Net income | profit | 303.33M | 91.73% |
| Provision for income taxes | cost | 40.27M | -47.00% |
| Segment | Value | YoY |
|---|---|---|
| UNITED STATES | 1.17B | 19.35% |
| Europe | 92.43M | 34.71% |
| Other Countries | 8.78M | 221.69% |
| Segment | Value | YoY |
|---|---|---|
| JAKAFI | 757.75M | 6.81% |
| OPZELURA | 143.01M | 20.48% |
| JAKAVI Royalty Revenues | 105.56M | 14.55% |
| NIKTIMVO | 55.09M | 304.67% |
| MINJUVI/MONJUVI | 49.23M | 66.58% |
| ZYNYZ | 41.39M | 1275.64% |
| OLUMIANT Royalty Revenues | 36.41M | 18.20% |
| ICLUSIG | 35.46M | 20.03% |
| PEMAZYRE | 22.54M | 22.25% |
| Milestone And Contract Revenues | 17.00M | |
| TABRECTA Royalty Revenues | 5.98M | -6.72% |
| Other Product Royalty Revenues | 3.25M | 156.48% |
| Item | Category | Value | YoY |
|---|---|---|---|
| Cash and cash equivalents | assets | 3.46B | |
| Accounts receivable | assets | 1.05B | |
| Marketable securities—available-for-sale (amortized cost $555,202 and $480,793 as of march 31, 2026 and december 31, 2025, respectively; allowance for credit losses $0 as of march 31, 2026 and december 31, 2025) | assets | 554.71M | |
| Prepaid expenses and other current assets | assets | 301.31M | |
| Inventory | assets | 115.62M | |
| Total current assets | assets | 5.48B | |
| Property and equipment, net | assets | 720.17M | |
| Deferred income tax asset | assets | 452.52M | |
| Inventory | assets | 331.42M | |
| Goodwill | assets | 133.00M | |
| Other intangible assets, net | assets | 110.16M | |
| Long term equity investments | assets | 54.58M | |
| Finance lease right-of-use assets, net | assets | 26.67M | |
| Other assets, net | assets | 24.49M | |
| Restricted cash | assets | 1.84M | |
| Total assets | assets | 7.34B | |
| Total liabilities | liabilities | 1.72B | |
| Total stockholders’ equity | equity | 5.62B | |
| Total current liabilities | liabilities | 1.49B | |
| Other liabilities | liabilities | 126.59M | |
| Acquisition-related contingent consideration | liabilities | 70.62M | |
| Finance lease, liability, noncurrent | liabilities | 29.41M | |
| Additional paid-in capital | equity | 5.08B | |
| Retained earnings | equity | 517.10M | |
| Accumulated other comprehensive income | equity | 22.31M | |
| Common stock, value, issued | equity | 200000 | |
| Accrued and other current liabilities | liabilities | 1.09B | |
| Accounts payable | liabilities | 228.62M | |
| Accrued compensation | liabilities | 124.92M | |
| Acquisition-related contingent consideration | liabilities | 39.38M | |
| Finance lease liabilities | liabilities | 4.41M |
| Item | Value |
|---|---|
| Net income (loss), including portion attributable to noncontrolling interest | 303.33M |
| Stock-based compensation | 64.13M |
| Deferred income taxes and tax credits | 63.42M |
| Depreciation and amortization | 23.80M |
| Accounts payable | 23.45M |
| Other noncash income (expense) | 12.77M |
| Increase (decrease) in prepaid expense and other assets | 9.19M |
| (gain) loss on change in fair value of acquisition-related contingent consideration | -168000 |
| Gain (loss) on equity investments | -6.59M |
| Increase (decrease) in inventories | -12.23M |
| Increase (decrease) in accounts receivable | -27.03M |
| Accrued and other liabilities | -84.72M |
| Item | Value |
|---|---|
| Maturities of marketable securities | 69.70M |
| Payments to acquire intangible assets | -5.00M |
| Payments to acquire other productive assets | -10.20M |
| Payments to acquire marketable securities | -142.70M |
| Item | Value |
|---|---|
| Proceeds from issuance of common stock under stock plans | 97.92M |
| Finance lease, principal payments | -1.18M |
| Payment for contingent consideration liability, financing activities | -4.96M |
| Payment, tax withholding, share-based payment arrangement | -6.96M |
| Item | Value |
|---|---|
| Cash and cash equivalents, beginning of period | 3.10B |
| Cash and cash equivalents, end of period | 3.46B |
快速穿透 10-K/10-Q 复杂数据。通过利润表及资产负债表桑基图，与现金流量表瀑布图，一站式洞悉企业财务流向。
在左侧搜索公司并选择一份报告。
申请股票支持